Definition

A vaccine containing inactivated Wistar rabies virus strain PM-1503-3M, with immunotherapeutic activity. Upon administration, Wistar rabies virus strain PM-1503-3M vaccine induces the formation of rabies-specific antibodies and rabies virus neutralizing antibodies (RVNA), which provide protection against rabies infection. This rabies vaccine can be used for both pre-exposure and post-exposure prophylaxis of rabies.